For the Inventor, By the Inventor

Enter inventor name

St-Genis-les-Ollieres, France

Michel Joseph Bublot

USPTO Granted Patents = 28 (Patent Applications = 7)

CIPO Patents = 8

EPO Patents = 14 (Patent Applications = 19)

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 262(Granted Patents)

Location History:

Saint-Genis-Les-Ollieres, FR (1998 - 2000)
St-Genis-les-Ollieres, FR (1999 - 2000)
Les Olieres, FR (2000)
St Genis les Olieres, FR (2001)
Delmar, NY (US) (2002 - 2007)
Chaponost, BE (2011)
Chaponost, FR (2013 - 2022)

Company Filing History:

Boehringer Ingelheim Animal Health USA Inc.

4. 1 out of 842

University of Georgia Research Foundation, Inc.

Biolex Therapeutics, Inc.

7. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Loading Chart...

Loading Chart...

28 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12385068 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2025-08-12),

2. 12280106 - Modified Marek's disease virus, and vaccines made therefrom (2025-04-21),

3. 11510978 - Modified Marek's disease virus, and vaccines made therefrom (2022-11-29),

4. 11421249 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2022-08-23),

5. 10822620 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2020-11-03),

6. 10350286 - Newcastle disease virus vectored avian vaccines (2019-07-16),

7. 10323257 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2019-06-18),

8. 9770502 - Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof (2017-09-26),

9. 9616118 - Newcastle disease virus vectored avian vaccines (2017-04-11),

10. 9555096 - Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof (2017-01-31),

11. 9446118 - Newcastle disease virus vectored herpesvirus vaccines (2016-09-20),

12. 9114108 - Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof (2015-08-25),

13. 9101598 - Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof (2015-08-11),

14. 8986706 - Newcastle disease virus vectored herpesvirus vaccines (2015-03-24),

15. 8871220 - Newcastle disease virus vectored avian vaccines (2014-10-28),

Title: Inventor Michel Joseph Bublot

Introduction: Michel Joseph Bublot is a renowned inventor hailing from St-Genis-les-Ollieres, France. He has made significant contributions to the field of innovation with his groundbreaking inventions.

Latest Patents: Michel Joseph Bublot holds several patents in various technological areas, showcasing his versatility and creativity in inventing new solutions to existing problems.

Career Highlights: Throughout his career, Michel Joseph Bublot has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His inventions have had a lasting impact on industries ranging from healthcare to telecommunications.

Collaborations: Michel Joseph Bublot has collaborated with leading research institutions and companies to bring his inventions to life. His ability to work with diverse teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Michel Joseph Bublot stands as a visionary inventor whose passion for innovation continues to inspire others in the field. His contributions have left a lasting legacy in the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…